Nektar Therapeutics (NKTR) earnings, May 7, 2026: EPS +49%, stock −1.8%
In brief
Nektar Therapeutics reported on May 7, 2026. Earnings per share changed +49% year over year, 15.0% below the estimate; revenue +4%. The stock opened with a +1.9% gap and closed the day −1.8% (May 8, 2026). The stock is now 66.8% below its 52-week high, −33.4% over 12 months. Next report: Nov 12, 2026.
EPS vs estimate−15.0%
EPS, YoY+49%
Revenue, YoY+4%
Gap · day+1.9% · −1.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 7, 2026 | +1.9% | −1.8% |
Next-quarter estimates, ratings and the NKTR chart are in the terminal.
Open the terminalFAQ
When is Nektar Therapeutics's next earnings report?
Nov 12, 2026. The date comes from daily data and is corrected if the company moves it.
How did Nektar Therapeutics stock react to the report?
Opening gap +1.9%, day's result −1.8%.
Did Nektar Therapeutics's earnings grow?
Earnings per share rose 49% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.